KhaledHamawiMDMHA, FASN

PubMed

• 5 citations
  Transplant tourism following the declaration of Istanbul: Poor outcomes and nephrologist dilemma.
  AlBugami, M. M., AlBugami, M. M., AlOtaibe, F. E., AlOtaibe, F. E., Alabadi, A. M., AlAbadi, A. M., Hamawi, K., Hamawi, K., Bel'eed-Akkari, K., Bel'eed-Akkari, K.> ;Nephrology (Carlton, Vic.). 2017 Oct 17
• Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial
  F G Cosio, K Hamawi, T S Larson, M J Mazur, H Amer, R L Heilman, R Kumar, M D Stegall> ;Wiley. 2013 Jun
• 9 citations
  Cost analysis of kidney transplantation in highly sensitized recipients compared to intermittent maintenance hemodialysis
  Ahmed Al-Jedai, Mohammed S. Alsultan, Khalid Almeshari, Khalid Alshaibani, Hazem Elgamal, Delal Alkortas, Fowad Khurshid, Mai Altalhi, Khaled Hamawi> ;Annals of Transplantation. 2012 Dec 31
• Hyperglycemia During the Immediate Period After Kidney Transplantation
  Raymond L Heilman, Khaled Hamawi, Adyr A Moss, Marek J Mazur, Kristin L Mekeel, Harini A Chakkera, Kunam S Reddy, David C Mulligan, Curtiss B Cook, Fernando G Cosio> ;Journal of the American Society of Nephrology. 2009 Apr
• 57 citations
  Outcomes of renal transplantation following bone marrow transplantation.
  Khaled Hamawi, Margarida De Magalhaes-Silverman, J. Andrew Bertolatus> ;American Journal of Transplantation. 2003 Mar 1
• The Kidney Transplant Program at King Faisal Specialist Hospital and Research Center.
  Al-Meshari, K., Al-Shaibani, K., Hamawi, K., Al-Akash, S., Raza, S., Tbakhi, A., Chaballout, A., Ahmadi, I., Al-Saghier, M., Al-Jedai, A., Mohamed, G. e. l. . D., Al-...> ;Clin Transpl. 2005
• Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
  Hakeam, H. A., Al-Jedai, A. H., Raza, S. M., Hamawi, K.> ;Ann Transplant. 2008
• Plasmapheresis therapy for rare but potentially fatal reaction to rituximab.
  Hastings, D., Patel, B., Torloni, A. S., Mookadam, F., Betcher, J., Moss, A., Heilman, R., Mazur, M., Hamawi, K., Mulligan, D., Reddy, K., Mekeel, K., Chakkera, H.> ;J Clin Apher. 2009 Jan 01
• Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus.
  Chakkera, H. A., Knowler, W. C., Devarapalli, Y., Weil, E. J., Heilman, R. L., Dueck, A., Mulligan, D. C., Reddy, K. S., Moss, A. A., Mekeel, K. L., Mazur, M. J., Hama...> ;Clin J Am Soc Nephrol. 2010 Sep
• Pretransplant risk score for new-onset diabetes after kidney transplantation.
  Chakkera, H. A., Weil, E. J., Swanson, C. M., Dueck, A. C., Heilman, R. L., Reddy, K. S., Hamawi, K., Khamash, H., Moss, A. A., Mulligan, D. C., Katariya, N., Knowler,...> ;Diabetes Care. 2011 Oct
• Use of bortezomib for treatment of antibody medicated rejection in kidney transplant recipients--case report.
  Hamawi, K., Heilman, R. L., Mazur, M. J., Chakkera, H. A., Mulligan, D. C., Moss, A. A., Mekeel, K. L., Reddy, K. S.> ;Clin Transpl. 2009
• Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.
  Chakkera, H. A., Hanson, R. L., Raza, S. M., DiStefano, J. K., Millis, M. P., Heilman, R. L., Mulligan, D. C., Reddy, K. S., Mazur, M. J., Hamawi, K., Moss, A. A., Mek...> ;Transplant Proc. 2009 Dec
• Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabe...
  Chakkera, H. A., Bodner, J. K., Heilman, R. L., Mulligan, D. C., Moss, A. A., Mekeel, K. L., Mazur, M. J., Hamawi, K., Ray, R. M., Beck, G. L., Reddy, K. S.> ;Transplant Proc. 2010 Sep
• Deceased donor kidney transplantation from donors with acute renal failure due to rhabdomyolysis.
  Mekeel, K. L., Moss, A. A., Mulligan, D. C., Chakkera, H. A., Hamawi, K., Mazur, M. J., Heilman, R. L., Reddy, K. S.> ;Am J Transplant. 2009 Jul 01
• Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients.
  Heilman, R. L., Devarapalli, Y., Chakkera, H. A., Mekeel, K. L., Moss, A. A., Mulligan, D. C., Mazur, M. J., Hamawi, K., Williams, J. W., Reddy, K. S.> ;Am J Transplant. 2010 Mar
• Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin.
  Reddy, K. S., Devarapalli, Y., Mazur, M., Hamawi, K., Chakkera, H., Moss, A., Mekeel, K., Post, D., Heilman, R., Mulligan, D.> ;Transplant Proc. 2010 Jul 01
• Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal.
  Heilman, R. L., Nijim, S., Chakkera, H. A., Devarapalli, Y., Moss, A. A., Mulligan, D. C., Mazur, M. J., Hamawi, K., Williams, J. W., Reddy, K. S.> ;J Transplant. 2011
• Resolution of long-standing necrobiosis lipoidica diabeticorum (NLD) lesion after restoration of euglycemia following successful pancreas after kidney (PAK) transplant...
  Mazur, M. J., Lowney, A. C., Prigoff, J., Heilman, R. L., Chakkera, H., Moss, A., Mulligan, D., Reddy, K., Hamawi, K.> ;Transplant Proc. 2011 Nov
• Join now to see all

Journal Articles

• Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial  
  Amer H, Griffin MD, Stegall MD, Cosio FG, Park WD, Kremers WK, Heilman RL, Mazur MJ, Hamawi K, Larson TS, Kumar R, Am J Transplant, 1/1/2013
• Successful transplantation of a split crossed fused ectopic kidney into a patient with end-stage renal disease  
  Mekeel KL, Daley SM, Andrews PE, Moss AA, Heilman RL, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, Sudhakar Reddy K, J Transplant, 1/1/2010
• Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial  
  Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirol..., Transplantation, 1/27/2009

Abstracts/Posters

• Toward a Saudi Calculated PRA: Similarities and Differences with UNOS Calculator.
  Al Zahrani S, Shawhatti A, Liacini A, Borkar M, Tripathi G, Awaji M, Al Saghier M, Housawi A, Hamawi K, AlAttas R, AlOtaibi A, Khan F, Berka N, Journal of Human Immunology, 1/1/2013
• Profile of Inflammatory Markers before and after Kidney Transplantation; Correlation to New-Onset Diabetes Mellitus after Kidney Transplantation.
  Chakkera H, Chang Y, Few J, Pitta T, Heilman R, Reddy K, Moss A, Mulligan D, Khamash H, Hamawi K, Katariya N, Hewitt W, Mandarino L, Am J Transplant, 1/1/2012
• Seroconversion Rate and Other Clinical Outcomes in Recipients of Kidneys from Centers for Disease Control (CDC) Risk Deceased Donors.
  Bodner J, Katariya N, Hewitt W, Moss A, Mulligan D, Heilman R, Chakkera H, Hamawi K, Khamash H, Beck G, Reddy K, Am J Transplant, 1/1/2012
• 1 Year Protocol Biopsy (Bx) Findings in Recipients of Kidneys from Donors with Acute Kidney Injury (AKI) Are Similar to Recipients of Non AKI Donor Kidneys.
  Heilman R, Smith M, Chakkera H, Khamash H, Hamawi K, , Moss A, Mulligan D, Hewitt W, Reddy K, Am J Transplant, 1/1/2012
• Baseline Biopsy Findings and Clinical Outcomes in Recipients of Kidneys from Standard Criteria Donors (SCD) with Acute Kidney Injury (AKI).
  Reddy K, Smith M, Chakkera H, Moss A, Mulligan D, Khamash H, Hewitt W, Katariya N, Hamawi K, Heilman R, Am J Transplant, 1/1/2012
• Comparable Patient and Graft Outcomes in Recipients of Expanded Criteria Donor (ECD) and Older Recipients of Standard Criteria Donor (SCD) Kidneys.
  Sando S, Chakkera H, Bodner J, Devarapali Y, Heilman R, Hamawi K, Mulligan D, Moss A, Reddy K, Am J Transplant, 1/1/2012
• Kidney Transplant Outcomes Using Donors with Diffuse Glomerular Fibrin Thrombi (DGFT).
  Smith M, Heilman R, Chakkera H, Khamash H, Hamawi K, Moss A, Katariya N, Hewitt W, Mulligan D, Reddy K, Am J Transplant, 1/1/2012
• Cost analysis of kidney transplantation in highly sensitized recipients compared to intermittent maintenance hemodialysis.
  Al-Jedai A, Alsultan M, Almeshari M, Alshaibani K, Elgamal H, Alkortas D, Khurshid F, Altalhi M, Hamawi K, Ann Transplant, 1/1/2012
• Oral Paricalcitol in Kidney Transplant Recipients Receiving a Corticosteroid-Free Immunosuppressive Regimen: An Open Label Randomized Trial.
  Amer H, Griffin M, Cosio F, Park W, Kremers W, Mazur M, Hamawi K, Larson T, Stegall M, Kumar R, Am J Transplant, 1/1/2012
• Equivalent measures in insulin resistance at 1 year post transplant among "select" type 2 diabetics receiving SPKTx, type 1 diabetics receiving SPKTx and non diabetics...
  Chakkera H, Bodner J, Patel S, Lambert R, Heilman R, Mulligan D, Moss A, Hamawi K, Petersen A, Reddy K, Am J Transplant, 1/1/2011
• Pre-transplant risk score predicts development of new onset diabetes mellitus after kidney transplantation.
  Chakkera H, Dueck A, Weil E, Cook C, Swanson C, Heilman R, Reddy K, Hamawi K, Moss A, Mulligan D, Knowler W, Am J Transplant, 1/1/2011
• Improved quality of life post kidney transplantation.
  Chakkera H, Wu Q, Pitta T, Heilman R, Reddy K, Mulligan D, Moss A, Hamawi K, Dueck A, Am J Transplant, 1/1/2011
• Comparison of 1-yr protocol biopsy findings in kidney transplant recipients on rapid steroid withdrawal (RSW) getting induction with either alemtuzumab (alem), rabbit-...
  Heilman R, Nijim S, Chakkera H, Hamawi K, Williams J, Moss A, Mulligan D, Reddy KS, Am J Transplant, 1/1/2011
• Induction with either alemtuzumab, r-ATG or basiliximab associated with similar outcomes in kidney transplant recipients on rapid steroid withdrawal.
  Reddy KS, Nijim S, Chakker H, Hamawi K, Williams J, Moss A, Mulligan D, Heilman R, Am J Transplant, 1/1/2011
• Comparison of insulin resistance post transplant among type 2 diabetics receiving SPK transplant to type 1 diabetics receiving SPK and to non-diabetics receiving kidne...
  Chakkera H, Bodner J, Heilman RL, Mulligan DC, Mazur MJ, Moss AA, Mekeel KL, Hamawi K, Reddy KS, Am J Transplant, 1/1/2010
• Predictive risk of pre-transplant fasting glucose on the development of new onset diabetes after kidney transplantation.
  Chakkera H, Devarapalli Y, Weil EJ, Mazur MJ, Hamawi K, Reddy KS, Mulligan DC, Moss AA, Mekeel KL, Heilman RL, Am J Transplant, 1/1/2010
• Influence of modest hypertension on the 1 year protocol biopsy (chronic interstitial fibrosis and tubular atrophy scores) among kidney transplant recipients on rapid s...
  Chakkera H, Devarapalli Y, Mulligan D, Reddy K, Moss A, Mekeel K, Mazur M, Hamawi K, Heilman R, Am J Transplant, 1/1/2010
• Subclinical acute rejection is associated with inferior graft survival in kidney transplant recipients on rapid steroid withdrawal.
  Heilman RL, Devarapalli Y, Chakkera H, Mekeel K, Moss A, Williams J, Hamawi K, Mazur M, Mulligan D, Reddy KS, Am J Transplant, 1/1/2010
• Simultaneous pancreas kidney transplantation in select type 2 DM: single center experience.
  Chakkera H, Bodner J, Heilman R, Mazur M, Mulligan D, Moss A, Hamawi K, Mekeel K, Lambert R, Reddy K, Am J Transplant, 1/1/2009
• Risk factors influencing graft and patient survival in kidney transplant recipients above 65 years of age.
  Chakkera H, Devarapalli Y, Mulligan D, Heilman R, Weil J, Moss A, Mazur M, Hamawi K, Mekeel K, Ray R, Beck G, Reddy K, Am J Transplant, 1/1/2009
• Immediate post-transplant inpatient hyperglycemia is predictive with new-onset diabetes mellitus after kidney transplant.
  Chakkera H, Devarapalli Y, Weil J, Heilman R, Mazur M, Hamawi K, Mulligan D, Reddy K, Moss A, Mekeel K, Ray R, Beck G, Petrides S, Cook C, Am J Transplant, 1/1/2009
• Magnitude and consequences of de novo hyperglycemia immediately post kidney transplantation (FC052).
  Chakkera HA, Devarapalli Y, Heilman RL, Mazur MJ, Hamawi K, Mulligan D, Reddy K, Moss A, Mekeel K, Cook C, J Am Soc Nephrol, 1/1/2009
• Quality of life (QOL) is improved after living donor kidney transplant among patients on steroid avoidance regimen (PO2039).
  Chakkera HA, Gordon A, Wu Q, Mazur M, Hamawi K, Mulligan D, Reddy K, Moss A, Mekeel K, Heilman R, J Am Soc Nephrol, 1/1/2009
• Pretransplant predictors of posttransplant new onset diabetes mellitus after kidney transplantation (PO-1000).
  Chakkera HA, Sexton DJ, Heilman RL, Mazur MJ, Hamawi K, Mulligan D, Reddy K, Moss A, Mekeel K, Knowler W, J Am Soc Nephrol, 1/1/2009
• Impact of subclinical inflammation (SCI) on the interstitial fibrosis and tubular atrophy score (IFTA) on 1 year protocol biopsy in kidney transplant recipients (KTx) ...
  Heilman R, Devarapalli Y, Chakkera H, Mazur M, Mekeel K, Moss A, Hamawi K, Mulligan D, Reddy K, Am J Transplant, 1/1/2009
• Join now to see all

Lectures

• "Malignancy Post Kidney Transplantation" 
  King Fahad Hospital - Al Hassa, Saudi Arabia - 1/1/2013
• "International Guidelines and Standards for Workup and Assessment of the Kidney Donor" 
  Abu Dhabi, United Arab Emirates - 1/1/2012
• "Virtual Cross Match and cPRA, Impact on Utilization and Allocation" 
  Abu Dhabi, United Arab Emirates - 1/1/2012
• "Experience with Kidney Transplantation in Highly Sensitized Patients" 
  Dammam, Saudi Arabia - 1/1/2010
• "Kidney Transplantation in Highly Sensitized Patients" 
  Corpus Christi, TX - 1/1/2010
• "Clinical Pathology Case" 
  Jeddah, Saudi Arabia - 1/1/2007
• "Introduction to Solid Organ Transplantation" 
  King Faisal Specialist Hospital & Research Center - 1/1/2006
• Non-infectious Post-Transplant complications. 
  King Faisal Specialist Hospital & Research Center - 1/1/2006
• "Current Status of Organ Donation in Saudi Arabia" 
  King Faisal Specialist Hospital & Research Center - 1/1/2005
• Post-transplant complications. 
  King Abdulaziz University Medical School - 1/1/2004
• Pre-transplant evaluation for potential recipients. 
  1/1/2003
• Join now to see all

Other

• Metabolic Acidosis. 
  Thomas C, Hamawi K, Nephrology Online Textbook
  1/1/2000